With RFK Jr. nominated for Secretary of the Department of Health & Human Services, these are all the agencies, including the ...

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...

Seattle's Zillow Group announced a new COO, while Vouched hired a new CTO. Fred Hutch created and filled the new title of ...

Understanding what to patent versus what to keep as a trade secret is an increasingly important and challenging decision ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

Bob Jones University covers tuition for some South Carolina residents. Samaritan Biologics expands its Greenville factory. Goodwill revamps Upstate presence.

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

Following strong treatment response data for Adaptimmune’s lete-cel, the biotech is planning to initiate a rolling BLA ...

Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

An expert witness told a U.S. House committee this week that America’s military is operating secret UFO programs and has recovered nonhuman “biologics” from crash sites. The U.S. House Committee on ...

From company acquisitions to FDA nods, here are six key updates in orthobiologics since Oct. 4. 1. RTI Surgical, a healthcare biologics company, plans to acquire Collagen Solutions. 2. Tetrous, a ...